Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1

Gianluigi Forloni, Federica Demicheli, Sussana Giorgi, Caterina Bendotti, Nadia Angeretti

Research output: Contribution to journalArticle

197 Citations (Scopus)

Abstract

The origin of β-amyloid deposited in senile plaques in Alzheimer's disease (AD) is not known. We compared the expression of protein precursor of β-amyloid (APP) in the cell types involved in plaque formation. The levels of APP mRNA were determined in primary rat neurons and glial cells in culture, human endothelial cells and in a murine brain-derived endothelial cell line. Northern blot analysis was performed using an APP cDNA probe to detect the general APP sequence and an oligonucleotide (40 mer) complementary to the sequence of the Kunitz protease inhibitor (APP-KPI). The APP mRNA transcripts were abundant in all three cell types. The highest level of APP, normalized to β-actin mRNA content, was expressed in neurons, followed by glial cells, where the APP expression was similar (94%) while in endothelial cells was lower (53%). The proportion between APP-KPI mRNA and total APP mRNA was high in endothelial, intermediate in glial and low in neuronal cells. We compared the effects of exposure to interleukin-1 (IL-1), a cytokine involved in several biological processes and elevated in AD, on APP mRNA expression in neuronal, glial and endothelial cells. In human endothelial and in brain-derived murine endothelial cells we observed a similar increase (50%) of total APP-mRNA or APP-KPI mRNA after treatment with human recombinant IL-1β. In neuronal cells, IL-1 (200 ng/ml) substantially increased APP mRNA (175%), detected with both probes. In glial cells, the expression of APP mRNA did not appear to be altered by IL-1 (50-400 ng/ml). The results suggest a role of IL-1 in the neuronal mechanism related to β-amyloid protein deposition in AD.

Original languageEnglish
Pages (from-to)128-134
Number of pages7
JournalMolecular Brain Research
Volume16
Issue number1-2
DOIs
Publication statusPublished - 1992

Fingerprint

Amyloid beta-Protein Precursor
Interleukin-1
Neuroglia
Endothelial Cells
Messenger RNA
Alzheimer Disease
Amyloidogenic Proteins
Biological Phenomena
Neurons
Amyloid Plaques
Brain
Protease Inhibitors
Amyloid
Oligonucleotides
Northern Blotting
Actins
Complementary DNA
Cell Culture Techniques
Cytokines
Cell Line

Keywords

  • Alzheimer's disease
  • Astrocyte
  • Cytokine
  • Gene expression
  • β-Amyloid

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells : modulation by interleukin-1. / Forloni, Gianluigi; Demicheli, Federica; Giorgi, Sussana; Bendotti, Caterina; Angeretti, Nadia.

In: Molecular Brain Research, Vol. 16, No. 1-2, 1992, p. 128-134.

Research output: Contribution to journalArticle

@article{7cb8658b8c39463a93666c004e16dc62,
title = "Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1",
abstract = "The origin of β-amyloid deposited in senile plaques in Alzheimer's disease (AD) is not known. We compared the expression of protein precursor of β-amyloid (APP) in the cell types involved in plaque formation. The levels of APP mRNA were determined in primary rat neurons and glial cells in culture, human endothelial cells and in a murine brain-derived endothelial cell line. Northern blot analysis was performed using an APP cDNA probe to detect the general APP sequence and an oligonucleotide (40 mer) complementary to the sequence of the Kunitz protease inhibitor (APP-KPI). The APP mRNA transcripts were abundant in all three cell types. The highest level of APP, normalized to β-actin mRNA content, was expressed in neurons, followed by glial cells, where the APP expression was similar (94{\%}) while in endothelial cells was lower (53{\%}). The proportion between APP-KPI mRNA and total APP mRNA was high in endothelial, intermediate in glial and low in neuronal cells. We compared the effects of exposure to interleukin-1 (IL-1), a cytokine involved in several biological processes and elevated in AD, on APP mRNA expression in neuronal, glial and endothelial cells. In human endothelial and in brain-derived murine endothelial cells we observed a similar increase (50{\%}) of total APP-mRNA or APP-KPI mRNA after treatment with human recombinant IL-1β. In neuronal cells, IL-1 (200 ng/ml) substantially increased APP mRNA (175{\%}), detected with both probes. In glial cells, the expression of APP mRNA did not appear to be altered by IL-1 (50-400 ng/ml). The results suggest a role of IL-1 in the neuronal mechanism related to β-amyloid protein deposition in AD.",
keywords = "Alzheimer's disease, Astrocyte, Cytokine, Gene expression, β-Amyloid",
author = "Gianluigi Forloni and Federica Demicheli and Sussana Giorgi and Caterina Bendotti and Nadia Angeretti",
year = "1992",
doi = "10.1016/0169-328X(92)90202-M",
language = "English",
volume = "16",
pages = "128--134",
journal = "Molecular Brain Research",
issn = "0169-328X",
publisher = "Elsevier BV",
number = "1-2",

}

TY - JOUR

T1 - Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells

T2 - modulation by interleukin-1

AU - Forloni, Gianluigi

AU - Demicheli, Federica

AU - Giorgi, Sussana

AU - Bendotti, Caterina

AU - Angeretti, Nadia

PY - 1992

Y1 - 1992

N2 - The origin of β-amyloid deposited in senile plaques in Alzheimer's disease (AD) is not known. We compared the expression of protein precursor of β-amyloid (APP) in the cell types involved in plaque formation. The levels of APP mRNA were determined in primary rat neurons and glial cells in culture, human endothelial cells and in a murine brain-derived endothelial cell line. Northern blot analysis was performed using an APP cDNA probe to detect the general APP sequence and an oligonucleotide (40 mer) complementary to the sequence of the Kunitz protease inhibitor (APP-KPI). The APP mRNA transcripts were abundant in all three cell types. The highest level of APP, normalized to β-actin mRNA content, was expressed in neurons, followed by glial cells, where the APP expression was similar (94%) while in endothelial cells was lower (53%). The proportion between APP-KPI mRNA and total APP mRNA was high in endothelial, intermediate in glial and low in neuronal cells. We compared the effects of exposure to interleukin-1 (IL-1), a cytokine involved in several biological processes and elevated in AD, on APP mRNA expression in neuronal, glial and endothelial cells. In human endothelial and in brain-derived murine endothelial cells we observed a similar increase (50%) of total APP-mRNA or APP-KPI mRNA after treatment with human recombinant IL-1β. In neuronal cells, IL-1 (200 ng/ml) substantially increased APP mRNA (175%), detected with both probes. In glial cells, the expression of APP mRNA did not appear to be altered by IL-1 (50-400 ng/ml). The results suggest a role of IL-1 in the neuronal mechanism related to β-amyloid protein deposition in AD.

AB - The origin of β-amyloid deposited in senile plaques in Alzheimer's disease (AD) is not known. We compared the expression of protein precursor of β-amyloid (APP) in the cell types involved in plaque formation. The levels of APP mRNA were determined in primary rat neurons and glial cells in culture, human endothelial cells and in a murine brain-derived endothelial cell line. Northern blot analysis was performed using an APP cDNA probe to detect the general APP sequence and an oligonucleotide (40 mer) complementary to the sequence of the Kunitz protease inhibitor (APP-KPI). The APP mRNA transcripts were abundant in all three cell types. The highest level of APP, normalized to β-actin mRNA content, was expressed in neurons, followed by glial cells, where the APP expression was similar (94%) while in endothelial cells was lower (53%). The proportion between APP-KPI mRNA and total APP mRNA was high in endothelial, intermediate in glial and low in neuronal cells. We compared the effects of exposure to interleukin-1 (IL-1), a cytokine involved in several biological processes and elevated in AD, on APP mRNA expression in neuronal, glial and endothelial cells. In human endothelial and in brain-derived murine endothelial cells we observed a similar increase (50%) of total APP-mRNA or APP-KPI mRNA after treatment with human recombinant IL-1β. In neuronal cells, IL-1 (200 ng/ml) substantially increased APP mRNA (175%), detected with both probes. In glial cells, the expression of APP mRNA did not appear to be altered by IL-1 (50-400 ng/ml). The results suggest a role of IL-1 in the neuronal mechanism related to β-amyloid protein deposition in AD.

KW - Alzheimer's disease

KW - Astrocyte

KW - Cytokine

KW - Gene expression

KW - β-Amyloid

UR - http://www.scopus.com/inward/record.url?scp=0026452028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026452028&partnerID=8YFLogxK

U2 - 10.1016/0169-328X(92)90202-M

DO - 10.1016/0169-328X(92)90202-M

M3 - Article

C2 - 1334190

AN - SCOPUS:0026452028

VL - 16

SP - 128

EP - 134

JO - Molecular Brain Research

JF - Molecular Brain Research

SN - 0169-328X

IS - 1-2

ER -